PRUEBA RÁPIDA

Investigador para formular el antígeno CePAD de prueba rápida en el Centro de Investigación Biotecnológica Molecular y la Universidad de Bioinformática Padjadjaran, Bandung, Java Occidental, jueves (21/5/2020). The University of Padjadjaran cooperated with Tekad Mandiri Citra and Pakar Biomedika Indonesia created and manufactured Rapid Test CePAD Antigen to detect the presence of viruses in COVID-19 handling or other infected diseases. ANTARA PHOTO/M Agung Rajasa/aww.

The caption is automatically translated by application. Click here for the Bahasa Indonesia version.